Development and validation of a nomogram for predicting prostate cancer in men with prostate-specific antigen grey zone based on retrospective analysis of clinical and multi-parameter magnetic resonance imaging/transrectal ultrasound fusion-derived data

BACKGROUND: Urologists face a dilemma when deciding whether prostate biopsy is required for patients with prostate-specific antigen (PSA) levels in the grey zone (4 to 10 ng/mL). METHODS: We retrospectively analyzed data from consecutive patients with PSA levels in grey zone, who underwent targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Zhimin, Wu, Huaiyu, Song, Di, Tian, Hongtian, Ye, Xiuqin, Liang, Weiyu, Jiao, Yang, Hu, Jintao, Xu, Jinfeng, Dong, Fajin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658138/
https://www.ncbi.nlm.nih.gov/pubmed/33209682
http://dx.doi.org/10.21037/tau-20-1154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658138/
https://www.ncbi.nlm.nih.gov/pubmed/33209682
http://dx.doi.org/10.21037/tau-20-1154

Ejemplares similares